REGN
Regeneron Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +5.3% ·
aandelenstroom -4.9% ·
netto nieuwe posities +5.0%
· formule
Fragmentatie van eigendom: meer houders, kleiner totaalbelang
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 5 | -2 | 489.34K | $362.44M | n/a | −2 |
| Q2 2026 | 169 | -1 | 76.12M | $47.53B | +5 | −5 |
| Q1 2026 | 172 | -4 | 77.87M | $60.04B | +2 | −7 |
| Q4 2025 | 175 | 0 | 81.03M | $62.54B | +1 | n/a |
| Q3 2025 | 27 | -1 | 48.96M | $27.52B | n/a | −2 |
| Q2 2025 | 26 | +2 | 40.24M | $21.12B | +3 | −1 |
| Q1 2025 | 21 | +1 | 16.62M | $10.53B | +1 | n/a |
| Q4 2024 | 20 | -1 | 17.24M | $12.28B | n/a | −1 |
| Q3 2024 | 20 | +1 | 13.10M | $13.76B | +2 | −1 |
| Q2 2024 | 19 | n/a | 13.77M | $14.47B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Capital World Investors ✦ | 4.30M | -7.3% | $4.52B | 0.7% | ▼ Trim | 2 | SEC ↗ |
| 2 | Dodge & Cox ✦ | 2.31M | -0.2% | $2.43B | 1.4% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 2.27M | -5.9% | $2.38B | 0.2% | ▼ Trim | 2 | SEC ↗ ×2 |
| 4 | T. Rowe Price ✦ | 1.28M | +36.7% | $1.34B | 0.2% | ▲ Add | 2 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passief) | 1.12M | -0.4% | $1.18B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 440.61K | -58.5% | $463.19M | 0.1% | ▼ Trim | 2 | SEC ↗ ×8 |
| 7 | D. E. Shaw & Co. ✦ | 266.24K | +4.7% | $279.88M | 0.4% | ▲ Add | 2 | SEC ↗ ×2 |
| 8 | AQR Capital Management ✦ | 225.53K | +19.1% | $235.23M | 0.3% | ▲ Add | 2 | SEC ↗ ×3 |
| 9 | Renaissance Technologies ✦ | 211.42K | +14.2% | $222.26M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 201.17K | -24.7% | $211.48M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 169.64K | +4.4% | $178.33M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 12 | Marshall Wace ✦ | 134.00K | +127.6% | $140.87M | 0.2% | ▲ Add | 2 | SEC ↗ ×2 |
| 13 | Citadel Advisors ✦ | 70.26K | -35.9% | $73.86M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 14 | Viking Global Investors ✦ | 49.87K | Nieuw | $52.43M | 0.2% | New | 1 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 22.39K | Nieuw | $23.54M | 0.1% | New | 1 | SEC ↗ |
| 16 | ARK Investment Management ✦ | 15.15K | -4.5% | $15.93M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 17 | Gotham Asset Management ✦ | 5.63K | -1.3% | $5.92M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 5.06K | -10.7% | $5.32M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Bridgewater Associates ✦ | 557 | -89.6% | $585,541 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | GAMCO Investors ✦ | 365 | +18.9% | $383,703 | 0.0% | ▲ Add | 2 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Viking Global Investors | $52.43M | 0.2% |
| Two Sigma Investments | $23.54M | 0.1% |
Verlaten
| Point72 Asset Management | $24.04M | was 0.1% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1,385 houders, 83.52M aandelen, $61.43B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 50 aand · $39,074
Officer · 127 aand · $97,701
Officer · 12 aand · $9,242
Officer · 283 aand · $218,351
Officer · 211 aand · $163,010
Officer · 224 aand · $173,242
Officer · 121 aand · $93,712
Officer · 376 aand · $291,573
Officer · 66 aand · $51,236
Officer · 38 aand · $29,555
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie